These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 2145440)
1. Phase II trial of trimetrexate in the treatment of recurrent childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. Pappo A; Dubowy R; Ravindranath Y; Alvarado C; Rao S; Whitehead VM; Vega R; Kamen B; Vietti T J Natl Cancer Inst; 1990 Oct; 82(20):1641-2. PubMed ID: 2145440 [No Abstract] [Full Text] [Related]
2. Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Land VJ; Shuster JJ; Crist WM; Ravindranath Y; Harris MB; Krance RA; Pinkel D; Pullen DJ J Clin Oncol; 1994 Sep; 12(9):1939-45. PubMed ID: 8083715 [TBL] [Abstract][Full Text] [Related]
3. A phase II trial of continuous-infusion 6-mercaptopurine for childhood leukemia. Adamson PC; Zimm S; Ragab AH; Balis F; Steinberg SM; Kamen BA; Vietti TJ; Gillespie A; Poplack DG Cancer Chemother Pharmacol; 1992; 30(2):155-7. PubMed ID: 1600597 [TBL] [Abstract][Full Text] [Related]
4. Phase II trial of trimetrexate in patients with advanced soft-tissue sarcoma. Licht JD; Gonin R; Antman KH Cancer Chemother Pharmacol; 1991; 28(3):223-5. PubMed ID: 1830249 [TBL] [Abstract][Full Text] [Related]
5. A phase II study of continuous infusion of trimetrexate in patients with refractory acute leukemia. Kheradpour A; Berman E; Göker E; Lin JT; Tong WP; Bertino JR Cancer Invest; 1995; 13(1):36-40. PubMed ID: 7834472 [TBL] [Abstract][Full Text] [Related]
6. [Clinical study on mitoxantrone contained regimen for treatment of newly diagnosed childhood acute lymphoblastic leukemia]. Wang WQ; Liu XY; Liu LQ Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):602-3. PubMed ID: 16137060 [No Abstract] [Full Text] [Related]
7. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study. Mahoney DH; Shuster JJ; Nitschke R; Lauer SJ; Steuber CP; Winick N; Camitta B J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of children with recurrent acute lymphoblastic leukemia]. Sotnikova NI Pediatriia; 1989; (4):62-5. PubMed ID: 2734065 [No Abstract] [Full Text] [Related]
9. Phase II trial of mitoxantrone in acute lymphocytic leukemia of childhood. A Pediatric Oncology Group study. Graham ML; Estrada J; Ragab AH; Starling KA; Rosen D; Wilkenson RW Invest New Drugs; 1991 Aug; 9(3):263-7. PubMed ID: 1783526 [TBL] [Abstract][Full Text] [Related]
10. Phase II study of trimetrexate in malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group study. Iscoe NA; Eisenhauer EA; Bodurtha AJ Invest New Drugs; 1990 Feb; 8(1):121-3. PubMed ID: 2140563 [TBL] [Abstract][Full Text] [Related]
11. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402. Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M; Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899 [TBL] [Abstract][Full Text] [Related]
12. Phase II study of trimetrexate in recurrent anaplastic glioma. National Cancer Institute of Canada Clinical Trials Group Study. Cairncross JG; Eisenhauer EA; Macdonald DR; Rathbone MP; Moore MJ; Sawka CA; MacCormick RE; Kerr IG Can J Neurol Sci; 1990 Feb; 17(1):21-3. PubMed ID: 2138053 [TBL] [Abstract][Full Text] [Related]
13. Protracted intermittent schedule of topotecan in children with refractory acute leukemia: a pediatric oncology group study. Furman WL; Stewart CF; Kirstein M; Kepner JL; Bernstein ML; Kung F; Vietti TJ; Steuber CP; Becton DL; Baruchel S; Pratt C J Clin Oncol; 2002 Mar; 20(6):1617-24. PubMed ID: 11896112 [TBL] [Abstract][Full Text] [Related]
14. Treatment of metastatic malignant melanoma with trimetrexate: a phase II study. Odujinrin O; Goldberg D; Doroshow J; Leong L; Margolin K; Grove W; Carr B; Akman S Med Pediatr Oncol; 1990; 18(1):49-52. PubMed ID: 2136764 [TBL] [Abstract][Full Text] [Related]
15. Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study. Mahoney DH; Shuster JJ; Nitschke R; Lauer S; Steuber CP; Camitta B J Clin Oncol; 2000 Mar; 18(6):1285-94. PubMed ID: 10715299 [TBL] [Abstract][Full Text] [Related]
16. Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study. Koh KN; Im HJ; Kim H; Kang HJ; Park KD; Shin HY; Ahn HS; Lee JW; Yoo KH; Sung KW; Koo HH; Lim YT; Park JE; Park BK; Park HJ; Seo JJ J Korean Med Sci; 2017 Apr; 32(4):642-649. PubMed ID: 28244291 [TBL] [Abstract][Full Text] [Related]